文献速递主动脉疾病

破裂腹主动脉瘤的EVAR优先策略可能不适用于所有病例

Endovascular Aneurysm Repair-First Strategy for Ruptured Abdominal Aortic Aneurysm Might Not Be Applicable to all Cases.
PubMed 文献 · Ann Vasc Surg · 2024-05-28

基于纽约州(2016年)和新泽西州、马里兰州、佛罗里达州(2016-2017年)的行政数据库,纳入8825例接受开放主动脉修复(OAR)或腔内主动脉修复(EVAR)的患者。整体医院病例量对完整及破裂AAA修复的院内死亡率无显著影响,但高OAR病例量医院中破裂AAA开放修复的死亡率显著低于低病例量医院,且与破裂AAA的EVAR相当。作者认为EVAR优先策略可能不适用于所有破裂AAA病例。

要点

  • 整体医院病例量对iEVAR、rEVAR及iOAR的院内死亡率无显著影响。
  • 高OAR病例量医院中rOAR死亡率显著低于低四分位医院(23.1% vs 44.7%)。
  • 在高OAR病例量医院,rEVAR死亡率高于rOAR(HR=2.3)。

核心结论

  • iEVAR、rEVAR和iOAR的死亡率与医院病例量无关,但rOAR在高OAR病例量医院死亡率更低,且至少与rEVAR相当。
  • 作者认为EVAR优先策略可能不适用于所有破裂AAA病例,个体化治疗应作为金标准;临床安全时,需rOAR的患者应鼓励转至区域卓越中心。

研究设计与样本

  • 基于医疗成本与利用项目数据库(纽约州2016年;新泽西州、马里兰州、佛罗里达州2016-2017年)的回顾性队列研究,使用ICD-10编码识别接受OAR和EVAR的患者。
  • 共纳入8825例患者(平均年龄73.5±9.5岁;男性6861例[77.7%]),其中OAR 1355例,EVAR 7470例;医院按总体(EVAR+OAR)病例量、单纯OAR病例量和单纯EVAR病例量分为四分位。
  • 采用校正混杂因素的Cox回归估计死亡风险比(HR)。

主要发现

  • 按总体医院病例量分析,iEVAR院内死亡率范围为0.7%-1.4%(P=0.15),rEVAR为20.5%-29.6%(P=0.63),iOAR为4.9%-8.8%(P=0.63),各四分位间无显著差异。
  • 按总体病例量分析,最高病例量(Q4)医院rOAR死亡率显著低于3个较低四分位医院(23.1% vs 44.7%,P<0.001)。
  • 按单纯OAR病例量分析,Q4医院rOAR死亡率显著低于Q1-3医院(22.0% vs 41.6%,P<0.001)。
  • 在按单纯OAR病例量分析的Q4医院中,rEVAR死亡率(39.0%)高于rOAR(22.0%)(HR=2.3,95%CI 1.02-5.34,P<0.05)。

临床怎么用

  • 作者认为EVAR优先策略可能不适用于所有破裂AAA病例,个体化治疗应作为金标准。
  • 作者建议,临床安全时,需要rOAR的患者应鼓励转至区域卓越中心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluate the relationship between the hospital case volume (HCV) and mortality outcomes after open aortic repair (OAR) and endovascular aortic repair (EVAR) of intact (iEVAR) and ruptured (rEVAR) abdominal aortic aneurysm (AAA) using a contemporary administrative database. METHODS: The Healthcare Cost and Utilization Project Database for New York (2016) and New Jersey/Maryland/Florida (2016-2017) were queried using International Classification of Disease-10th edition to identify patients who had undergone OAR and EVAR. The hospitals were categorized into quartiles (Q) per overall (EVAR + OAR) volume, OAR-alone volume and EVAR-alone volume. Cox regression adjusted for confounding factors was used to estimate hazard ratios (HRs) for mortality. RESULTS: A total of 8,825 patients (mean age, 73.5 ± 9.5 years; 6,861 male [77.7%]) had undergone 1,355 OARs and 7,470 EVARs. Overall HCV had no impact on in-hospital mortality across quartiles after (iEVAR) (range, 0.7%-1.4%, P = 0.15), (rEVAR) (range, 20.5%-29.6%, P = 0.63) and open repair of intact AAA (iOAR) (range, 4.9%-8.8%, P = 0.63). However, the mortality rates after open repair of ruptured AAA (rOAR) in highest-volume (Q4) hospitals were significantly lower than those in the 3 lower quartile hospitals (23.1% vs. 44.7%, P < 0.001). When analyzed per OAR-alone volume, the same findings were observed (22.0% for Q4 vs. 41.6% for Q1-3, P < 0.001). Furthermore, in Q4 hospitals per the OAR-alone volume analysis, the mortality hazard was greater for rEVAR (39.0%) than for rOAR (22.0%) (HR = 2.3, 95% confidence interval, 1.02-5.34, P < 0.05). CONCLUSIONS: The mortality rates for iEVAR, rEVAR and iOAR were independent of HCV. However, after rOAR, mortality rates in high OAR volume hospitals were lower than those in the lower quartile hospitals, and, at least comparable to those of rEVAR. EVAR-first strategy for ruptured AAA might not be applicable to all cases. Patent-specific, individualized treatment should be the gold standard. For patients requiring rOAR, transfer to a regional center of excellence, when clinical safe, should be encouraged.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lim S, Pawar O, d'Audiffret A, et al. Endovascular Aneurysm Repair-First Strategy for Ruptured Abdominal Aortic Aneurysm Might Not Be Applicable to all Cases. Ann Vasc Surg. 2024. PMID: 38815909. doi:10.1016/j.avsg.2024.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。